Publisher: Elsevier

Related content
Volume 10, Number 20, 16 October 2000

< previous issue | all issues | next issue >

Favourites:Add to Favourites
Favourites:Add to Favourites

Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists
pp. 2247-2250(4)
Authors: Wang, Y.; Chackalamannil, S.; Hu, Z.; Clader, J.W.; Greenlee, W.; Billard, W.; Binch, H.; Crosby, G.; Ruperto, V.; Duffy, R.A.; McQuade, R.; Lachowicz, J.E.

Favourites:Add to Favourites

Differential antibacterial activity of moenomycin analogues on gram-positive bacteria
pp. 2251-2254(4)
Authors: Goldman, R.C.; Baizman, E.R.; Branstrom, A.A.; Longley, C.B.

Favourites:Add to Favourites

Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor
pp. 2255-2257(3)
Authors: Kozlowski, J.A.; Lowe, D.B.; Guzik, H.S.; Zhou, G.; Ruperto, V.B.; Duffy, R.A.; McQuade, R.; Crosby, G.; Taylor, L.A.; Billard, W.; Binch, H.; Lachowicz, J.E.

Favourites:Add to Favourites
Favourites:Add to Favourites

Analogues of SB-203207 as inhibitors of tRNA synthetases
pp. 2263-2266(4)
Authors: Banwell, M.G.; Crasto, C.F.; Easton, C.J.; Forrest, A.K.; Karoli, T.; March, D.R.; Mensah, L.; Nairn, M.R.; O'Hanlon, P.J.; Oldham, M.D.; Yue, W.

Favourites:Add to Favourites

Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors
pp. 2267-2270(4)
Authors: Llinas-Brunet, M.; Bailey, M.; Fazal, G.; Ghiro, E.; Gorys, V.; Goulet, S.; Halmos, T.; Maurice, R.; Poirier, M.; Poupart, M.; Rancourt, J.; Thibeault, D.; Wernic, D.; Lamarre, D.

Favourites:Add to Favourites

NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain
pp. 2271-2274(4)
Authors: LaPlante, S.R.; Aubry, N.; Bonneau, P.R.; Kukolj, G.; Lamarre, D.; Lefebvre, S.; Li, H.; Llinas-Brunet, M.; Plouffe, C.; Cameron, D.R.

Favourites:Add to Favourites

Synthesis and preliminary analysis of a P-glycoprotein-specific [3H]-benzophenone photoaffinity label based on (-)-stipiamide
pp. 2275-2278(4)
Authors: Andrus, M.B.; Turner, T.M.; Sauna, Z.E.; Ambudkar, S.V.

Favourites:Add to Favourites

Metal mediated protease inhibition: design and synthesis of inhibitors of the human cytomegalovirus (hCMV) protease
pp. 2279-2282(4)
Authors: Dhanak, D.; Burton, G.; Christmann, L.T.; Darcy, M.G.; Elrod, K.C.; Kaura, A.; Keenan, R.M.; Link, J.O.; Peishoff, C.E.; Shah, D.H.

Favourites:Add to Favourites

Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human 3 adrenergic receptor agonists
pp. 2283-2286(4)
Authors: Parmee, E.R.; Brockunier, L.L.; He, J.; Singh, S.B.; Candelore, M.R.; Cascieri, M.A.; Deng, L.; Liu, Y.; Tota, L.; Wyvratt, M.J.; Fisher, M.H.; Weber, A.E.

Favourites:Add to Favourites

DNA triplex structures are stabilized by the incorporation of 3'-endo blocked pyrimidine nucleosides in the hoogsteen strand
pp. 2287-2289(3)
Authors: Savy, P.; Benhida, R.; Fourrey, J.; Maurisse, R.; Sun, J.

Favourites:Add to Favourites

Synthesis and enzymatic evaluation of a P1 arginine aminocoumarin substrate library for trypsin-like serine proteases
pp. 2291-2294(4)
Authors: Edwards, P.D.; Mauger, R.C.; Cottrell, K.; Morris, F.X.; Pine, K.K.; Sylvester, M.A.; Scott, C.W.; Furlong, S.T.

Favourites:Add to Favourites

N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists
pp. 2295-2299(5)
Authors: Tsai, Y.; Dukat, M.; Slassi, A.; MacLean, N.; Demchyshyn, L.; Savage, J.E.; Roth, B.L.; Hufesein, S.; Lee, M.; Glennon, R.A.

Favourites:Add to Favourites
Favourites:Add to Favourites

Novel, potent and selective chimeric FXa inhibitors featuring hydrophobic p1-ketoamide moieties
pp. 2305-2309(5)
Authors: Semple, J.E.; Levy, O.E.; Minami, N.K.; Owens, T.D.; Siev, D.V.

Favourites:Add to Favourites

Synthesis of derivatives of NK109, 7-OH Benzo[c]phenanthridine alkaloid, and evaluation of their cytotoxicities and reduction-resistant properties
pp. 2321-2323(3)
Authors: Nakanishi, T.; Masuda, A.; Suwa, M.; Akiyama, Y.; Hoshino-Abe, N.; Suzuki, M.

Favourites:Add to Favourites

Design and synthesis of a novel water soluble benzotetrazepinone
pp. 2325-2327(3)
Authors: Dumont-Hornebeck, B.; Strube, Y.N.; Vasilescu, D.; Jean-Claude, B.J.

Favourites:Add to Favourites

The design and synthesis of novel NK1/NK2 dual antagonists
pp. 2329-2332(4)
Authors: Reichard, G.A.; Ball, Z.T.; Aslanian, R.; Anthes, J.C.; Shih, N.; Piwinski, J.J.

Favourites:Add to Favourites

Synthesis and NK1/NK2 receptor activity of substituted-4(Z)-(methoxyimino)pentyl-1-piperazines
pp. 2333-2335(3)
Authors: Ting, P.C.; Lee, J.F.; Anthes, J.C.; Shih, N.; Piwinski, J.J.

Favourites:Add to Favourites

Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 1
pp. 2337-2341(5)
Authors: Furet, P.; Caravatti, G.; Denholm, A.A.; Faessler, A.; Fretz, H.; Garca-Echeverra, C.; Gay, B.; Irving, E.; Press, N.J.; Rahuel, J.; Schoepfer, J.; Walker, C.V.

Favourites:Add to Favourites

Structure-based design and synthesis of phosphinate isosteres of phosphotyrosine for incorporation in Grb2-SH2 domain inhibitors. Part 2
pp. 2343-2346(4)
Authors: Walker, C.V.; Caravatti, G.; Denholm, A.A.; Egerton, J.; Faessler, A.; Furet, P.; Garca-Echeverra, C.; Gay, B.; Irving, E.; Jones, K.; Lambert, A.; Press, N.J.; Woods, J.

Favourites:Add to Favourites

1,2-disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors
pp. 2347-2351(5)
Authors: Takeuchi, K.; Bastian, J.A.; Gifford-Moore, D.S.; Harper, R.W.; Miller, S.C.; Mullaney, J.T.; Sall, D.J.; Smith, G.F.; Zhang?, M.; Fisher, M.J.

Favourites:Add to Favourites

Highly sensitive and rapid detection of antibody catalysis by luminescent bacteria
pp. 2353-2356(4)
Authors: Shulman, H.; Eberhard, A.; Eberhard, C.; Ulitzur, S.; Keinan, E.

Favourites:Add to Favourites

Dibasic inhibitors of human mast cell tryptase. Part 1: Synthesis and optimization of a novel class of inhibitors
pp. 2357-2360(4)
Authors: Rice, K.D.; Gangloff, A.R.; Kuo, E.Y.; Dener, J.M.; Wang, V.R.; Lum, R.; Newcomb, W.S.; Havel, C.; Putnam, D.; Cregar, L.; Wong, M.; Warne, R.L.

Favourites:Add to Favourites

Dibasic inhibitors of human mast cell tryptase. Part 2: Structure-activity relationships and requirements for potent activity
pp. 2361-2366(6)
Authors: Rice, K.D.; Wang, V.R.; Gangloff, A.R.; Kuo, E.Y.; Dener, J.M.; Newcomb, W.S.; Young, W.B.; Putnam, D.; Cregar, L.; Wong, M.; Simpson, P.J.

Favourites:Add to Favourites

Optimising inhibitors of Trypanothione reductase using solid-phase chemistry
pp. 2367-2369(3)
Authors: Chitkul, B.; Bradley, M.

Favourites:Add to Favourites

Chemical modification of nodulisporic acid A: preliminary structure-activity relationships
pp. 2371-2374(4)
Authors: Meinke, P.T.; Ayer, M.B.; Colletti, S.L.; Li, C.; Lim, J.; Ok, D.; Salva, S.; Schmatz, D.M.; Shih, T.L.; Shoop, W.L.; Warmke, L.M.; Wyvratt, M.J.; Zakson-Aiken, M.; Fisher, M.H.

Favourites:Add to Favourites

Novel heterocycles as selective α1-adrenergic receptor antagonists
pp. 2375-2377(3)
Authors: Li, X.; McCoy, K.A.; Murray, W.V.; Jolliffe, L.; Pulito, V.

Favourites:Add to Favourites

Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists
pp. 2379-2382(4)
Authors: Stark, H.; Ligneau, X.; Sadek, B.; Ganellin, C.R.; Arrang, J.; Schwartz, J.; Schunack, W.

Favourites:Add to Favourites

Synthesis and estrogen receptor binding affinities of novel pyrrolo[2,1,5-cd]indolizine derivatives
pp. 2383-2386(4)
Authors: Jorgensen, A.S.; Jacobsen, P.; Christiansen, L.B.; Bury, P.S.; Kanstrup, A.; Thorpe, S.M.; Naerum, L.; Wassermann, K.

Favourites:Add to Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more